Latest Press Releases

Press Release Oct 7, 2026
NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals

Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Injections
Press Release Sep 29, 2026
NexTel Medical Corp. Announces Strategic Joint Venture to Commercialize Breakthrough Patented Hair Regeneration Technology

Capitalizing on a Global Hair Restoration Market Projected to Exceed $23 Billion, the Venture Integrates Advanced Exosome Delivery to Eliminate Microneedling and Reactivate Follicles
Press Release Sep 25, 2026
NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference

Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer screening, sparking key vendor collaboration discussions.
Press Release Aug 6, 2026
NexTel Medical Corp. Clarifies and Expands Upon Remarks Made During Recent Online Discussion
Press Release Aug 5, 2026
NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC

Strategic Acquisition Positions NexTel at the Forefront of Precision Neuro-Restoration with Xycota's Breakthrough Exosome-Delivered Brain Circuitry Repair Platform and Pending FDA Orphan Drug Designation
Press Release Jul 28, 2026
NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals

Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies.